Literature DB >> 11738875

Molecular-cytogenetic investigation of skewed chromosome X inactivation in Rett syndrome.

Y B Yurov1, S G Vorsanova, A D Kolotii, I Y Iourov.   

Abstract

We have developed an approach to differentiate homologous X chromosomes in metaphase chromosomes and interphase nuclei by a fluorescence in situ hybridization (FISH) technique with chromosome X-specific alpha-satellite DNA probe. FISH analysis of metaphase chromosomes in a cohort of 33 girls with Rett syndrome (RTT) allowed us to detect eight girls with structurally different X chromosomes, one X chromosome with a large and another one with a small centromeric heterochromatin (so-called chromosomal heteromorphism). Step-wise application of differential replication staining and the FISH technique to identify the inactivation status of paternal and maternal chromosome X in RTT girls was applied. Skewed X inactivation in seven RTT girls with preferential inactivation of one X chromosome over the other X chromosome was detected in 62-93% of cells. Therefore, non-random or skewed X inactivation with variable penetrance in blood cells could take place in RTT.

Entities:  

Mesh:

Year:  2001        PMID: 11738875     DOI: 10.1016/s0387-7604(01)00370-9

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  3 in total

1.  Svetlana G. Vorsanova (1945-2021).

Authors:  Ivan Y Iourov
Journal:  Mol Cytogenet       Date:  2022-08-19       Impact factor: 1.904

2.  Xq28 (MECP2) microdeletions are common in mutation-negative females with Rett syndrome and cause mild subtypes of the disease.

Authors:  Ivan Y Iourov; Svetlana G Vorsanova; Victoria Y Voinova; Oxana S Kurinnaia; Maria A Zelenova; Irina A Demidova; Yuri B Yurov
Journal:  Mol Cytogenet       Date:  2013-11-27       Impact factor: 2.009

Review 3.  VIII World Rett Syndrome Congress & Symposium of rare diseases, Kazan, Russia.

Authors:  Ivan Y Iourov; Svetlana G Vorsanova; Yuri B Yurov; Thomas Bertrand
Journal:  Mol Cytogenet       Date:  2018-12-24       Impact factor: 2.009

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.